# Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

> **NCT00447902** · PHASE3 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 11 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** tipranavir
- **DRUG:** ritonavir

## Key facts

- **NCT ID:** NCT00447902
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2014-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447902, "Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00447902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*